Hobbs RF - Search Results

1

Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

Hobbs RF, Howell RW, Song H, Baechler S, Sgouros G. Hobbs RF, et al. Radiat Res. 2014 Jan;181(1):90-8. doi: 10.1667/RR13483.1. Radiat Res. 2014. PMID: 24502376 Free PMC article.

2

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.

Prideaux AR, Song H, Hobbs RF, He B, Frey EC, Ladenson PW, Wahl RL, Sgouros G. Prideaux AR, et al. Among authors: hobbs rf. J Nucl Med. 2007 Jun;48(6):1008-16. doi: 10.2967/jnumed.106.038000. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504874 Free PMC article.

3

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.

Baechler S, Hobbs RF, Prideaux AR, Wahl RL, Sgouros G. Baechler S, et al. Among authors: hobbs rf. Med Phys. 2008 Mar;35(3):1123-34. doi: 10.1118/1.2836421. Med Phys. 2008. PMID: 18404947 Free PMC article.

4

Three-dimensional imaging-based radiobiological dosimetry.

Sgouros G, Frey E, Wahl R, He B, Prideaux A, Hobbs R. Sgouros G, et al. Semin Nucl Med. 2008 Sep;38(5):321-34. doi: 10.1053/j.semnuclmed.2008.05.008. Semin Nucl Med. 2008. PMID: 18662554 Free PMC article. Review.

5

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF. Fu DX, et al. Among authors: hobbs rf. Nat Med. 2008 Oct;14(10):1118-22. doi: 10.1038/nm.1864. Epub 2008 Sep 7. Nat Med. 2008. PMID: 18776891 Free PMC article.

6

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.

Song H, Shahverdi K, Huso DL, Wang Y, Fox JJ, Hobbs RF, Gimi B, Gabrielson KL, Pomper MG, Tsui BM, Bhujwalla Z, Reilly RT, Sgouros G. Song H, et al. Among authors: hobbs rf. Clin Cancer Res. 2008 Oct 1;14(19):6116-24. doi: 10.1158/1078-0432.CCR-07-4672. Clin Cancer Res. 2008. PMID: 18829490 Free PMC article.

7

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan.

Baechler S, Hobbs RF, Prideaux AR, Recordon M, Bischof-Delaloye A, Sgouros G. Baechler S, et al. Among authors: hobbs rf. Cancer Biother Radiopharm. 2008 Oct;23(5):633-9. doi: 10.1089/cbr.2008.0506. Cancer Biother Radiopharm. 2008. PMID: 18999935 Free PMC article.

8

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL. Loeb DM, et al. Among authors: hobbs rf. Cancer. 2009 Jun 1;115(11):2514-22. doi: 10.1002/cncr.24286. Cancer. 2009. PMID: 19338063 Free PMC article. Clinical Trial.

9

Calculation of the biological effective dose for piecewise defined dose-rate fits.

Hobbs RF, Sgouros G. Hobbs RF, et al. Med Phys. 2009 Mar;36(3):904-7. doi: 10.1118/1.3070587. Med Phys. 2009. PMID: 19378750 Free PMC article.

10

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison.

Hobbs RF, Wahl RL, Lodge MA, Javadi MS, Cho SY, Chien DT, Ewertz ME, Esaias CE, Ladenson PW, Sgouros G. Hobbs RF, et al. J Nucl Med. 2009 Nov;50(11):1844-7. doi: 10.2967/jnumed.109.066738. Epub 2009 Oct 16. J Nucl Med. 2009. PMID: 19837771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters